EU regulatory committee recommends 8 new drugs for approval, including Bristol Myers’ BCMA CAR-T

At its June meeting, the European Medicine Agency’s Committee for Medicinal Products for Human Use recommended eight new drugs for approval, bringing this year’s count to 50 positive opinions.

While the European Commission doesn’t need to follow the CHMP’s recommendations, it typically does. Here are the drugs that got the...

Click to view original post